Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts

Citation:

Franklin JM, Donneyong MM, Desai RJ, Markson L, Girman CJ, McKay C, Patel MD, Mavros P, Schneeweiss S. Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts. J Comp Eff Res 2017;6(7):613-625.

Date Published:

2017 Oct

Abstract:

AIM: To assess heterogeneity in adherence to medications in two example comparative effectiveness research studies. PATIENTS & METHODS: We analyzed data from commercially insured patients initiating a statin or anticoagulant during 2005-2012. We calculated the cross-validated R from a series of hierarchical linear models to assess variation in 1-year adherence. RESULTS: There was less heterogeneity in adherence in the statin cohort compared with the anticoagulant cohort, where patient characteristics explained 7.2% of variation in adherence, and adding therapy and provider characteristics increased the proportion of variation explained to 8.0 and 8.5%, cumulatively. Random effects provided essentially no explanatory power, even in the statin cohort with large numbers of patients clustered within each pharmacy, prescriber and provider. CONCLUSION: The dependence of adherence on the healthcare system was stronger when the healthcare system influenced treatment choice and patient access to medication and when indications for treatment were strong.
Last updated on 01/29/2020